Table 1.

Demographic and clinical characteristics of the study cohort (n = 2465)

General characteristics
Age, mean (SD) 69.2 (9.1) 
Smoking, n (%) 241 (9.8%) 
Comorbidities, n (%)  
Eczema, n (%) 64 (2.6%) 
Coronary artery disease, n (%) 218 (8.8%) 
Hypertension, n (%) 634 (26.0%) 
Diabetes, n (%) 110 (4.5%) 
Thyroid disease, n (%) 517 (21%) 
Dyslipidemia, n (%) 445 (18.0%) 
Venous thrombosis, n (%) 123 (5.0%) 
Asthma, n (%) 183 (7.4%) 
Lupus, n (%) 9 (0.4%) 
Previous cancer, n (%) 259 (11.0%) 
CH status  
CHIP, n (%) 333 (14.0%) 
TET2 mutation, n (%) 103 (4.2%) 
DNMT3A mutation, n (%) 195 (7.9%) 
Peripheral blood counts  
Total white blood count, 109/L, mean (SD) 6.43 (1.63) 
Absolute lymphocyte count, 109/L, mean (SD) 1.86 (0.57) 
Absolute neutrophil count, 109/L, mean (SD) 3.93 (1.29) 
Absolute monocyte count, 109/L, mean (SD) 0.46 (0.16) 
Hemoglobin, g/L, mean (SD) 131.2 (9.67) 
Mean corpuscular volume, fL, mean (SD) 91.1 (3.9) 
Platelet count, 109/L, mean (SD) 249.2 (57.6) 
General characteristics
Age, mean (SD) 69.2 (9.1) 
Smoking, n (%) 241 (9.8%) 
Comorbidities, n (%)  
Eczema, n (%) 64 (2.6%) 
Coronary artery disease, n (%) 218 (8.8%) 
Hypertension, n (%) 634 (26.0%) 
Diabetes, n (%) 110 (4.5%) 
Thyroid disease, n (%) 517 (21%) 
Dyslipidemia, n (%) 445 (18.0%) 
Venous thrombosis, n (%) 123 (5.0%) 
Asthma, n (%) 183 (7.4%) 
Lupus, n (%) 9 (0.4%) 
Previous cancer, n (%) 259 (11.0%) 
CH status  
CHIP, n (%) 333 (14.0%) 
TET2 mutation, n (%) 103 (4.2%) 
DNMT3A mutation, n (%) 195 (7.9%) 
Peripheral blood counts  
Total white blood count, 109/L, mean (SD) 6.43 (1.63) 
Absolute lymphocyte count, 109/L, mean (SD) 1.86 (0.57) 
Absolute neutrophil count, 109/L, mean (SD) 3.93 (1.29) 
Absolute monocyte count, 109/L, mean (SD) 0.46 (0.16) 
Hemoglobin, g/L, mean (SD) 131.2 (9.67) 
Mean corpuscular volume, fL, mean (SD) 91.1 (3.9) 
Platelet count, 109/L, mean (SD) 249.2 (57.6) 

Entries correspond to frequency (%) for categorical data and mean (SD) for continuous data.

SD, standard deviation.

Close Modal

or Create an Account

Close Modal
Close Modal